Basking Ridge, NJNCT07029217Now EnrollingIRB Ready

B-Cell Lymphoma Clinical Trial in Basking Ridge, NJ

Access cutting-edge b-cell lymphoma treatment through this phase 3 clinical trial at a research site in Basking Ridge. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Basking Ridge location

Preparing your pre-screening questions…

Expert Care in Basking Ridge

Access b-cell lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related b-cell lymphoma treatment provided free

Apply for This Basking Ridge Location

Check if you qualify for this b-cell lymphoma clinical trial in Basking Ridge, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Basking Ridge

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Basking Ridge site if eligible
  4. 4Begin participation

About This B-Cell Lymphoma Study in Basking Ridge

The researchers are doing this study to find out whether a very low dose of radiation therapy (VLDRT) is an effective treatment for people with follicular lymphoma (FL) or marginal zone lymphoma (MZL) and works as well as the standard dose of radiation therapy. The researchers will see if VLDRT works against cancer in the area that is currently affected by cancer and if the therapy prevents new spots of lymphoma from developing. The researchers will also compare VLDRT with the standard dose of r

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

(Arms 1\&2)
Patients must be diagnosed with a follicular lymphoma or marginal zone lymphoma. Of note, there are now two widely-utilized pathology classification criteria used for mature B-cell lymphomas, the World Health Organization (WHO) 5th Edition Classification of Lymphoid Neoplasms and the International Consensus Classification (ICC) of Mature Lymphoid Neoplasms. Either criteria is acceptable and for the purposes of this protocol, the following diagnoses are included:
Follicular lymphoma
WHO 5th Edition
Classic follicular lymphoma (cFL)
Follicular lymphoma with uncommon features (uFL)
Pediatric type follicular lymphoma
Duodenal type follicular lymphoma
Follicular lymphoma, grades 1-2 or 3A
BCL2 rearrangement negative, CD23 positive follicle center lymphoma
Pediatric type follicular lymphoma
Duodenal type follicular lymphoma
Marginal zone lymphoma
WHO 5th Edition and ICC
Nodal marginal zone lymphoma
Pediatric nodal marginal zone lymphoma
Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT)
Patients must have stage I or II disease (with stage I defined as involvement of one nodal region and stage II as two or more nodal regions involved on the same side of the diaphragm)
Patients should be newly diagnosed or previously observed with no prior lymphoma-directed therapy
If the patient is referred for localized gastric MALT lymphoma, there should be documented negative H. Pylori testing within 6 months prior to proposed radiotherapy
Age at the time of enrollment of ≥18 years
Patients must be able to start radiation within 2 months from time of randomization

Exclusion Criteria

Prior radiation to site(s) needing treatment
Follicular lymphoma, grade 3B (ICC) or Follicular large B cell lymphoma (FLBL by WHO 5th edition criteria)
Patients planned to receive concurrent systemic therapy (including oral steroids) for their lymphoma
Patient has cutaneous only iNHL defined as primary cutaneous B-cell lymphoma, primary cutaneous follicle center lymphoma, cutaneous marginal zone lymphoma or unspecified indolent lymphoma of the skin
Gross total resection of all disease
Tumor size measuring ≥5 cm in maximum diameter on any modality diagnostic imaging
Patients with any concurrent medical or psychiatric condition or disease which, in the investigator's judgment, would make them inappropriate candidates for entry into this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Basking Ridge?

Yes, this clinical trial (NCT07029217) has an active research site in Basking Ridge, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

B-Cell Lymphoma Treatment Options in Basking Ridge, NJ

If you're searching for b-cell lymphoma treatment options in Basking Ridge, NJ, this clinical trial (NCT07029217) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Basking Ridge research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all b-cell lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Basking Ridge, NJ

See all lymphoma clinical trials recruiting in Basking Ridge — not just this study.

Browse Lymphoma Trials in Basking Ridge →

Browse More Trials by Condition

Lymphoma TrialsDiffuse Large B-Cell Lymphoma TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Basking Ridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Basking Ridge, NJ